Baxter InternationalBAX
BAX
About: Baxter International Inc offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
Employees: 38,000
0
Funds holding %
of 7,425 funds
0
Analysts bullish %
of 3 analysts
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
3.55% more ownership
Funds ownership: 90.85% [Q3] → 94.4% (+3.55%) [Q4]
9% less funds holding
Funds holding: 879 [Q3] → 803 (-76) [Q4]
15% less call options, than puts
Call options by funds: $91.6M | Put options by funds: $108M
20% less capital invested
Capital invested by funds: $17.6B [Q3] → $14.1B (-$3.5B) [Q4]
25% less funds holding in top 10
Funds holding in top 10: 8 [Q3] → 6 (-2) [Q4]
26% less repeat investments, than reductions
Existing positions increased: 243 | Existing positions reduced: 329
34% less first-time investments, than exits
New positions opened: 110 | Existing positions closed: 167
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$36
15%
upside
Avg. target
$40
27%
upside
High target
$42
35%
upside
3 analyst ratings
2 positive
67%
1 neutral
33%
0 negative
0%
Barclays Matt Miksic 48% 1-year accuracy 20 / 42 met price target | 32%upside $41 | Overweight Maintained | 10 Mar 2025 |
Goldman Sachs David Roman 30% 1-year accuracy 6 / 20 met price target | 35%upside $42 | Buy Reinstated | 26 Feb 2025 |
JP Morgan Robbie Marcus 41% 1-year accuracy 7 / 17 met price target | 16%upside $36 | Neutral Maintained | 21 Feb 2025 |
Financial journalist opinion
Based on 6 articles about BAX published over the past 30 days
Positive
Zacks Investment Research
6 hours ago
MedTech Stocks' Earnings to Watch on May 1: BDX, CAH, BAX, DXCM & SYK
This earnings season so far has reflected a continued recovery in sales for companies within the Medical sector. Earnings have increased year over year, albeit at a slower pace than revenues.
Neutral
Business Wire
1 day ago
Baxter to Present at Bank of America Securities 2025 Health Care Conference
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Bank of America Securities 2025 Health Care Conference on Tuesday, May 13, 2025. Joel Grade, Baxter's chief financial officer, is scheduled to present at 8:40 a.m. Pacific Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through Sunday, November 9, 2025. About Baxter Every day, millions of patients, caregivers and.
Positive
Zacks Investment Research
2 days ago
Will BAX's Q1 Earnings Improve Following Transformation Completion?
Baxter's first-quarter results are likely to reflect the favorable impact of kidney care sales. Growth in infusion therapies, pharmaceuticals and patient support systems to continue.
Positive
CNBC Television
1 week ago
Goldman's John Marshall provides stock opportunities ahead of earning season
John Marshall, Goldman Sachs head of derivatives research, joins 'Money Movers' to discuss the current market environment, individual companies Goldman looked at, and much more.
Neutral
Business Wire
2 weeks ago
Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery
VIENNA--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the introduction of Hemopatch Sealing Hemostat with room temperature storage at a symposium in Austria. The evolution of the product optimizes accessibility in the operating room, delivering an immediate solution for surgeons to control bleeding or prevent leakage. The product is now available to order throughout Europe. “For over a decade, Hemopatch Sealing Hemostat.
Neutral
Business Wire
2 weeks ago
Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery
VIENNA--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the introduction of Hemopatch Sealing Hemostat with room temperature storage at a symposium in Austria. The evolution of the product optimizes accessibility in the operating room, delivering an immediate solution for surgeons to control bleeding or prevent leakage. The product is now available to order throughout Europe. “For over a decade, Hemopatch Sealing Hemostat.
Neutral
Business Wire
1 month ago
Baxter to Host Annual Meeting of Stockholders in Virtual Format
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host its Annual Meeting of Stockholders (the 2025 Annual Meeting) in a virtual format on Tuesday, May 6, 2025 at 9 a.m., Central Time, as disclosed in Baxter's proxy statement for the 2025 Annual Meeting. Online access to the 2025 Annual Meeting will begin at 8:45 a.m., Central Time. Stockholders will not be able to attend the 2025 Annual Meeting in person. The virtual format provides a safe, c.
Positive
Market Watch
1 month ago
Stocks beating the stock market's recent Trump slump have this in common
This year's top performer among the S&P 500 has been CVS Health's stock, which had a bad 2024 and is cheap by a key valuation measure.
Positive
Zacks Investment Research
1 month ago
Baxter Stock Likely to Gain Following the Introduction of Voalte Linq
At the 2025 HIMSS Global Healthcare Conference, BAX unveils its Voalte Linq device, powered by Scotty assistant, a voice-activated technology.
Neutral
Business Wire
1 month ago
Baxter Unveils Voalte Linq Device Powered by Scotty Assistant at HIMSS25 to Advance Voice-Activated Technology in Hospital Settings
LAS VEGAS--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today unveiled Voalte Linq device powered by Scotty assistant, the company's first voice-activated technology, at the 2025 HIMSS Global Healthcare Conference. Voalte Linq, a lightweight, wearable badge, is powered by Scotty assistant, a voice-activated technology, to better enable efficient, streamlined communication between care teams, with the goal of freeing up more of their time and energy to focus on.
Charts implemented using Lightweight Charts™